Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. School of Medicine /醫學系
  4. On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy
 
  • Details
Options

On-treatment HBV DNA level could predict HBeAg seroclearance in patients with HBeAg-positive chronic hepatitis B with entecavir therapy

Journal
Journal of the Chinese Medical Association
Journal Volume
80
Journal Issue
6
Start Page
341-346
ISSN
1726-4901
Date Issued
2017-06
Author(s)
Yi-Jie Huang
Chi-Sen Chang
Yen-Chun Peng
Hong-Zen Yeh
Sheng-Shun Yang  
DOI
10.1016/j.jcma.2016.12.005
URI
https://scholars.csmu.edu.tw/handle/123456789/3536
SDGs

[SDGs]SDG3

[SDGs]SDG5

Publisher
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback